Cognition Therapeutics Inc — Quarterly Cash Flow (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 27.58 M30.23 M23.5 M19.62 M43.4 M Total liabilities 13.1 M11.48 M11.23 M12.59 M6.87 M Total equity 14.48 M18.75 M12.27 M7.03 M36.53 M Total liabilities & shareholders' equities 27.58 M30.23 M23.5 M19.62 M43.4 M Total debt ————— Net debt —————

ニュース

コグニション・セラピューティクス、レビー小体型認知症薬についてFDAと会議

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

コグニション社のDLB治療薬、第2相試験で良好な結果を示す

Cognition’s DLB drug shows positive results in phase 2 trial

コグニション・セラピューティクス、拡大アクセスプログラムの登録完了

Cognition Therapeutics completes enrollment in expanded access program

コグニション・セラピューティクス、アルツハイマー病薬の第3相試験計画を発表

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

コグニション・セラピューティクス、アルツハイマー病薬の治験登録完了

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?